Biltmore Family Office’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $853K | Hold |
9,308
| – | – | 0.11% | 126 |
|
|
2026
Q1 | $793K | Hold |
9,308
| – | – | 0.11% | 123 |
|
|
2025
Q4 | $736K | Hold |
9,308
| – | – | 0.1% | 122 |
|
|
2025
Q3 | $744K | Buy |
9,308
+3,200
| +52% | +$273K | 0.11% | 113 |
|
|
2025
Q2 | $555K | Sell |
6,108
-3,210
| -34% | -$293K | 0.09% | 119 |
|
|
2025
Q1 | $873K | Buy |
9,318
+3,600
| +63% | +$322K | 0.15% | 95 |
|
|
2024
Q4 | $520K | Hold |
5,718
| – | – | 0.09% | 122 |
|
|
2024
Q3 | $594K | Buy |
5,718
+20
| +0.4% | +$2.04K | 0.1% | 113 |
|
|
2024
Q2 | $553K | Hold |
5,698
| – | – | 0.1% | 106 |
|
|
2024
Q1 | $513K | Hold |
5,698
| – | – | 0.1% | 107 |
|
|
2023
Q4 | $454K | Hold |
5,698
| – | – | 0.09% | 115 |
|
|
2023
Q3 | $405K | Sell |
5,698
-57
| -1% | -$4.26K | 0.09% | 126 |
|
|
2023
Q2 | $443K | Hold |
5,755
| – | – | 0.09% | 118 |
|
|
2023
Q1 | $432K | Sell |
5,755
-18
| -0.3% | -$1.34K | 0.09% | 144 |
|
|
2022
Q4 | $455K | Buy |
5,773
+1
| +0% | +$75 | 0.09% | 133 |
|
|
2022
Q3 | $405K | Buy |
5,772
+17
| +0.3% | +$1.33K | 0.09% | 116 |
|
|
2022
Q2 | $461K | Hold |
5,755
| – | – | 0.12% | 111 |
|
|
2022
Q1 | $436K | Sell |
5,755
-4,998
| -46% | -$396K | 0.09% | 125 |
|
|
2021
Q4 | $918K | Hold |
10,753
| – | – | 0.17% | 86 |
|
|
2021
Q3 | $813K | Buy |
10,753
+4,996
| +87% | +$397K | 0.2% | 79 |
|
|
2021
Q2 | $468K | Hold |
5,757
| – | – | 0.13% | 104 |
|
|
2021
Q1 | $454K | Hold |
5,757
| – | – | 0.14% | 100 |
|
|
2020
Q4 | $492K | Sell |
5,757
-1,000
| -15% | -$82.7K | 0.15% | 90 |
|
|
2020
Q3 | $521K | Hold |
6,757
| – | – | 0.29% | 78 |
|
|
2020
Q2 | $495K | Hold |
6,757
| – | – | 0.3% | 83 |
|
|
2020
Q1 | $448K | Buy |
6,757
+757
| +13% | +$53.4K | 0.29% | 84 |
|
|
2019
Q4 | $413K | Sell |
6,000
-4,000
| -40% | -$273K | 0.17% | 117 |
|
|
2019
Q3 | $735K | Hold |
10,000
| – | – | 0.32% | 78 |
|
|
2019
Q2 | $717K | Hold |
10,000
| – | – | 0.39% | 65 |
|
|
2019
Q1 | $685K | Hold |
10,000
| – | – | 0.35% | 74 |
|
|
2018
Q4 | $595K | Hold |
10,000
| – | – | 0.34% | 78 |
|
|
2018
Q3 | $670K | Hold |
10,000
| – | – | 0.32% | 79 |
|
|
2018
Q2 | $648K | Hold |
10,000
| – | – | 0.32% | 79 |
|
|
2018
Q1 | $717K | Hold |
10,000
| – | – | 0.32% | 83 |
|
|
2017
Q4 | $755K | Buy |
+10,000
| New | +$730K | 0.34% | 78 |
|
Other funds holding CL
Biltmore Family Office's CL Position: Q2 2026 in Review
Biltmore Family Office held its Colgate-Palmolive (CL) position steady in Q2 2026 at 9,308 shares worth $853K. The position accounts for 0.11% of the portfolio, ranked #126.
Biltmore Family Office first reported a position in CL in Q4 2017 and has held it in 35 quarters since. The position peaked at $918K in Q4 2021. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Biltmore Family Office held 9,308 shares of Colgate-Palmolive worth $853K as of Q2 2026.
- Biltmore Family Office left its Colgate-Palmolive share count unchanged in Q2 2026.
- Colgate-Palmolive made up 0.11% of Biltmore Family Office's portfolio in Q2 2026, its #126 holding.
- Biltmore Family Office first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 35 quarters since.
- Biltmore Family Office's Colgate-Palmolive position peaked at $918K in Q4 2021.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.